Extra Corporeal Membrane Oxygenation System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By End-User, By Region and Competition, 2020-2030F

Description

Global Extra Corporeal Membrane Oxygenation (ECMO) System Market was valued at USD 571.20 Million in 2024 and is expected to reach USD 782.48 Million in the forecast period with a CAGR of 5.36% through 2030. The Extracorporeal Membrane Oxygenation (ECMO) System Market is experiencing significant expansion due to the growing demand for advanced life-support technologies in critical care settings. ECMO systems play a crucial role in managing patients with severe cardiac and respiratory failure by providing prolonged extracorporeal circulation and oxygenation. Increased awareness among healthcare professionals regarding the effectiveness of ECMO in improving survival rates has contributed to its widespread adoption. The integration of innovative features such as real-time monitoring, compact designs, and automation is further enhancing system performance and usability. Rising cases of cardiovascular diseases, respiratory disorders, and organ failure are driving the need for ECMO, particularly in intensive care units (ICUs) and specialized cardiac centers. Advancements in medical technologies are also improving patient outcomes, making ECMO a preferred intervention in life-threatening conditions.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 571.20 Million
Market Size 2030	USD 782.48 Million
CAGR 2025-2030	5.36%
Fastest Growing Segment	Hospitals & Clinics
Largest Market	North America

Advancements in ECMO technology are reshaping the market, leading to the development of portable and user-friendly systems. Increasing investments in research and development have resulted in devices with enhanced efficiency, reduced complications, and improved patient safety. The growing preference for minimally invasive and percutaneous ECMO cannulation techniques has reduced procedural risks and expanded the applicability of ECMO beyond traditional hospital settings. An increasing number of heart and lung transplant procedures also necessitate the use of ECMO for perioperative support, further driving market growth. The integration of artificial intelligence (AI) and data analytics is helping clinicians monitor and optimize ECMO performance, leading to better patient management. Favorable reimbursement policies in developed countries are enhancing patient access to ECMO therapy, while the growing focus on neonatal and pediatric care is expanding the target patient population. Collaborations between healthcare providers and medical device manufacturers are accelerating the adoption of ECMO systems, particularly in emerging markets where critical care infrastructure is rapidly developing.

Key Market Drivers

Advancements in Medical Technology

Advancements in medical technology have significantly enhanced extracorporeal membrane oxygenation (ECMO) systems, improving their efficacy, safety, and overall utility. These innovations are particularly crucial given the rising prevalence of cardiovascular diseases (CVDs) and respiratory failures, which are leading causes of mortality globally.

In the United States, heart disease remains the leading cause of death, accounting for 702,880 fatalities in 2022, which represents 1 in every 5 deaths. Coronary heart disease (CHD) is the most common type, responsible for 371,506 deaths in the same year. Additionally, about 1 in 20 adults aged 20 and older have CHD. Each year, approximately 805,000 Americans experience a heart attack, with 605,000 being first occurrences and 200,000 happening in individuals who have already had a heart attack.

Key Market Challenges

High Costs and Resource Intensity

ECMO therapy is a highly specialized and resource-intensive medical intervention. The equipment itself is expensive, and the overall cost of ECMO treatment includes not only the machine but also the required disposables, personnel, and infrastructure. Running an ECMO program demands a skilled team of healthcare professionals, including perfusionists and specially trained nurses, as well as dedicated facilities with the necessary technology and expertise.

Financial Burden: The high upfront costs associated with establishing and maintaining an ECMO program can be a substantial financial burden for healthcare institutions, particularly smaller hospitals and clinics. Due to the resource-intensive nature of ECMO, it may not be readily available in all healthcare settings, limiting access for patients in remote areas or regions with fewer healthcare resources. The cost barrier can exacerbate healthcare disparities, as not all patients may have equal access to ECMO treatment, potentially leading to unequal outcomes based on socioeconomic factors.

Key Market Trends

Technological Advancements and Miniaturization

One prominent trend in the global ECMO System Market is the continuous advancement of technology and the development of more compact, portable ECMO systems. This trend aims to make ECMO therapy more accessible and versatile.

Miniaturized ECMO Machines: Manufacturers are working on creating smaller, more portable ECMO machines that are easier to transport and set up. This makes ECMO treatment feasible in a wider range of healthcare settings, including ambulances and remote clinics. ECMO systems are increasingly being integrated with advanced monitoring devices and artificial intelligence algorithms. This integration allows for real-time monitoring of patient vitals, helping healthcare providers make informed decisions and detect complications earlier. Some ECMO systems now offer wireless connectivity, enabling healthcare teams to monitor patients remotely. This feature is especially valuable for critical care patients who require continuous monitoring even during inter-hospital transfers.

Key Market Players

LivaNova (Alung Technologies Inc.)
Eurosets
Getinge AB
Medtronic PLC
Microport Scientific Corporation
Nipro Medical Corporation
Terumo Medical Corporation
Abbott Laboratories
Fresenius Medical Care Company

Report Scope:

In this report, the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Modality:

Veno-Arterial (VA)
Veno-Venous (VV)
Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Application:

Respiratory Applications
Cardiac Applications
Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By End-User:

Hospitals & Clinics
Ambulatory Care Centers
Others

Extra Corporeal Membrane Oxygenation (ECMO) System Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market.

Available Customizations:

Global Extra Corporeal Membrane Oxygenation (ECMO) System market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Modality (Veno-Arterial (VA), Veno-Venous (VV), Others)
- 5.2.2. By Application (Respiratory Applications, Cardiac Applications, Extracorporeal Cardiopulmonary Resuscitation (ECPR))
- 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Modality
- 6.2.2. By Application
- 6.2.3. By End-User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Modality
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By End-User
- 6.3.2. Canada Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Modality
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By End-User
- 6.3.3. Mexico Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Modality
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By End-User

7. Europe Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Modality
- 7.2.2. By Application
- 7.2.3. By End-User
7.3. Europe: Country Analysis
- 7.3.1. Germany Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Modality
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By End-User
- 7.3.2. United Kingdom Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Modality
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By End-User
- 7.3.3. Italy Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Modality
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By End-User
- 7.3.4. France Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Modality
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By End-User
- 7.3.5. Spain Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Modality
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By End-User

8. Asia-Pacific Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Modality
- 8.2.2. By Application
- 8.2.3. By End-User
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Modality
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By End-User
- 8.3.2. India Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Modality
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By End-User
- 8.3.3. Japan Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Modality
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By End-User
- 8.3.4. South Korea Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Modality
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By End-User
- 8.3.5. Australia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Modality
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By End-User

9. South America Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Modality
- 9.2.2. By Application
- 9.2.3. By End-User
9.3. South America: Country Analysis
- 9.3.1. Brazil Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Modality
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By End-User
- 9.3.2. Argentina Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Modality
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By End-User
- 9.3.3. Colombia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Modality
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By End-User

10. Middle East and Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Modality
- 10.2.2. By Application
- 10.2.3. By End-User
10.3. MEA: Country Analysis
- 10.3.1. South Africa Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Modality
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By End-User
- 10.3.2. Saudi Arabia Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Modality
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By End-User
- 10.3.3. UAE Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Modality
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By End-User

11. Market Dynamics

11.1. Drivers & Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. Global Extra Corporeal Membrane Oxygenation (ECMO) System Market: SWOT Analysis

14. Competitive Landscape

14.5.1. LivaNova (Alung Technologies Inc.)
14.5.2. Eurosets
14.5.3. Getinge AB
14.5.4. Medtronic PLC
14.5.5. Microport Scientific Corporation
14.5.6. Nipro Medical Corporation
14.5.7. Terumo Medical Corporation
14.5.8. Abbott Laboratories
14.5.9. Fresenius Medical Care Company